Welmate Anti Diarrheal Loperamide Hcl Softgels Capsule
NDC Package 73581-102-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Welmate Anti Diarrheal Loperamide Hcl Softgels (loperamide hydrochloride) capsules is drink plenty of clear fluids to help prevent dehydration caused by diarrheanot for use in children under 12 years of ageadults and children 12 years and over: 2 softgels after the first loose stool; 1 softgel after each subsequent loose stool; but no more than 4 softgels in 24 hours. This formulation utilizes a capsule delivery system. Marketed by Yyba Corp, this product is identified by NDC 73581-102 and is authorized under FDA application NDA021855.

Identification & Billing

NDC Package Code
73581-102-24
Package Description
2 BLISTER PACK in 1 CARTON / 12 CAPSULE in 1 BLISTER PACK
Product Code
73581-102
11-Digit Billing Format
73581010224
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Welmate Anti Diarrheal Loperamide Hcl Softgels
Non-Proprietary Name
Loperamide Hydrochloride
Substance Name
Loperamide Hydrochloride
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
LOPERAMIDE HYDROCHLORIDE 2 mg/1
Pharmacologic Class
Usage Information
Drink plenty of clear fluids to help prevent dehydration caused by diarrheanot for use in children under 12 years of ageadults and children 12 years and over: 2 softgels after the first loose stool; 1 softgel after each subsequent loose stool; but no more than 4 softgels in 24 hours

Regulatory & Marketing

Labeler Name
Yyba Corp
Product Type
Human Otc Drug
FDA Application #
NDA021855
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
08-22-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73581-102-24 identifies a specific commercial package of 2 blister pack in 1 carton / 12 capsule in 1 blister pack of Welmate Anti Diarrheal Loperamide Hcl Softgels, a human over the counter drug labeled by Yyba Corp. This capsule is formulated for oral use and contains loperamide hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Yyba Corp on August 22, 2020. The current certification is valid through December 31, 2026.

How is this Yyba Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73581010224. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73581-102-24
11-Digit CMS (5-4-2)
73581-0102-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.